Ann: Incannex to Prepare IND Application for Psi-GAD, page-4

Well done BOD!

I might say, this is not new.
It has been the intention of the BOD for some time now to Open an IND with the FDA for the PSI-GAD program,
it was even mooted by Dr.Paul prior to previewing the interim results.

Since then, I think the resolve to "go with the IND Filing" was crystalized when Joel and another Executive from IHL had a private preview "for ongoing Commerical Considerations" at the midpoint when the DSMB report was accessing the data from the first 37 participants.



I really do like the cautious but methodical decision-making process that Joel and the team undertake when making important decisions like this.
The IHL-42X process was no different. A sneak peek at interim results from the Alfred, then the Patent Filing, then the extended study to UWA.
I digress!


You can see the same prudent and careful approach being taken by the BOD here with the PSI-GAD program, with some consistency now (since Bob has come on board)
I have noticed that some developmental advancements from the team are being made in parallel while the actual trial is still underway.

As with IHL-42x, IMO we can confidently presume that the results so far for the PSI-GAD are good, how good we will know later this year or early in 2024.

All happening in the background noise of the move to the NASDAQ, but for good reason "no doubt here!"

GLAH